SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,359,737 | +0.2% | 768,913 | -1.0% | 0.56% | -15.6% |
| Q4 2022 | $4,349,307 | -12.3% | 776,662 | +0.5% | 0.67% | -36.2% |
| Q3 2022 | $4,962,000 | +459.4% | 772,820 | +198.8% | 1.05% | +360.8% |
| Q2 2022 | $887,000 | -57.3% | 258,647 | -11.3% | 0.23% | -66.3% |
| Q1 2022 | $2,075,000 | -18.3% | 291,443 | -4.4% | 0.67% | -50.4% |
| Q4 2021 | $2,540,000 | – | 304,901 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |